MED - Medifast, Inc.
Baltimore, MD, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Weight regain after initial weight loss is a recognized pattern among individuals pursuing lasting metabolic change. Trilivy™, a science-backed, coach-guided metabolic health system, points to lean mass preservation and continued support as the two factors that keep metabolic health and its results in place.
MED's revenue is stabilizing as coach productivity and client retention improve, though a shrinking coach base continues to weigh on results.
Baltimore, MD, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Weight comes back after weight loss when the conditions that drove it were never addressed during the weight loss phase. Trilivy™, a science-backed, coach-guided comprehensive metabolic health system, points to five factors research identifies as drivers of weight regain, rooted in body composition and habit infrastructure.
Baltimore, MD, Oct. 01, 2026 (GLOBE NEWSWIRE) -- The signs of poor metabolic health can be difficult to analyze without a clinical framework. Trilivy™, a science-backed, coach-guided metabolic health system, points to five frequently overlooked patterns adults can recognize before noticeable weight and energy fluctuations.
Trilivy™ is designed to address the challenges of metabolic dysfunction Clients on Trilivy's Reset 5 & 1 Plan who work with a coach lose up to 10 times more weight and 17 times more fat compared to self-directed approaches* Baltimore, MD, Sept. 29, 2026 (GLOBE NEWSWIRE) -- A weight loss plateau is one of the most common reasons people abandon a structured weight loss effort altogether.
MED is shifting toward metabolic health with its 3.0 strategy, targeting broader growth, greater efficiency and a return to profitability.
Medifast (MED) reported earnings 30 days ago. What's next for the stock?
NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, Sept.
BALTIMORE--(BUSINESS WIRE)--Medifast, Inc. (NYSE: MED) has announced the launch of the Medifast Metabolic Health Institute, established to advance metabolic health through rigorous research and credible, evidence-based education. The institute brings Medifast's clinical research, scientific expertise, and educational resources under a single body, solidifying the company's position in the metabolic health space. It follows the July launch of Trilivy™, which replaced OPTAVIA® as the company's co.
MED's Trilivy launch marks a major metabolic-health shift, backed by a 10-year roadmap and growing GLP-1 market focus.
Medifast (MED) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Great Lakes Advisors LLC purchased a new position in shares of Medifast Inc (NYSE: MED) in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The fund purchased 51,611 shares of the specialty retailer's stock, valued at approximately $548,000. Great Lakes Advisors LLC owned approximately 0.46% of
MED is reshaping its coach network around Executive Directors as productivity rises despite a sharp decline in active earning coaches.
MED's improving coach productivity and client retention point to stabilization, but a shrinking coach base remains a challenge.
Medifast's low valuation and improving coach productivity offer potential, but a shrinking coach base and weak growth keep the turnaround high risk.
Medifast stock gains 13.6% in a month as improving coach productivity and earnings expectations support momentum despite weaker revenue.
Medifast's Trilivy launch and cost cuts could support a Q4 profit turnaround, but shrinking revenue and its coach base keep risks high.
Medifast, Inc. has started to report stabilizing sales through improved coach productivity, shown again in the Q2 report. Stabilized sales provide a pathway to stabilize earnings. MED targets profitability by Q4 already, but the target has to be taken with caution. Due to MED's $15.2 in net cash per share, the stock seems attractive. I estimate 44% upside to $18.8 on the condition that earnings improve near breakeven.
MED tops Q2 earnings expectations despite lower sales, as rising coach productivity helps offset pressure from a shrinking coach network.
Medifast, Inc. (MED) Q2 2026 Earnings Call Transcript